A Palatable Hyperlipidic Diet Causes Obesity and Affects Brain Glucose Metabolism in Rats

Background We have previously shown that either the continuous intake of a palatable hyperlipidic diet (H) or the alternation of chow (C) and an H diet (CH regimen) induced obesity in rats. Here, we investigated whether the time of the start and duration of these feeding regimens are relevant and whether they affect brain glucose metabolism. Methods Male Wistar rats received C, H, or CH diets during various periods of their life spans: days 30-60, days 30-90, or days 60-90. Experiments were performed the 60th or the 90th day of life. Rats were killed by decapitation. The glucose, insulin, leptin plasma concentration, and lipid content of the carcasses were determined. The brain was sliced and incubated with or without insulin for the analysis of glucose uptake, oxidation, and the conversion of [1-14C]-glucose to lipids. Results The relative carcass lipid content increased in all of the H and CH groups, and the H30-60 and H30-90 groups had the highest levels. Groups H30-60, H30-90, CH30-60, and CH30-90 exhibited a higher serum glucose level. Serum leptin increased in all H groups and in the CH60-90 and CH30-90 groups. Serum insulin was elevated in the H30-60, H60-90, CH60-90, CH30-90 groups. Basal brain glucose consumption and hypothalamic insulin receptor density were lower only in the CH30-60 group. The rate of brain lipogenesis was increased in the H30-90 and CH30-90 groups. Conclusion These findings indicate that both H and CH diet regimens increased body adiposity independent treatment and the age at which treatment was started, whereas these diets caused hyperglycemia and affected brain metabolism when started at an early age

Kinin B1 receptor controls maternal adiponectin levels and influences offspring weight gain

Given the importance of the kinin B1 receptor in insulin and leptin hormonal regulation, which in turn is crucial in maternal adaptations to ensure nutrient supply to the fetus, we investigated the role of this receptor in maternal metabolism and fetoplacental development. Wild-type and kinin B1 receptor-deficient (B1KO) female mice were mated with male mice of the opposite genotype. Consequently, the entire litter was heterozygous for kinin B1 receptor, ensuring that there would be no influence of offspring genotype on the maternal phenotype. Maternal kinin B1 receptor blockade reduces adiponectin secretion by adipose tissue ex vivo, consistent with lower adiponectin levels in pregnant B1KO mice. Furthermore, fasting insulinemia also increased, which was associated with placental insulin resistance, reduced placental glycogen accumulation, and heavier offspring. Therefore, we propose the combination of chronic hyperinsulinemia and reduced adiponectin secretion in B1KO female mice create a maternal obesogenic environment that results in heavier pups

Long-range Angular Correlations On The Near And Away Side In P-pb Collisions At √snn=5.02 Tev

7191/Mar294

Measurement of jet suppression in central Pb-Pb collisions at root s(NN)=2.76 TeV

The transverse momentum(p(T)) spectrum and nuclear modification factor (R-AA) of reconstructed jets in 0-10% and 10-30% central Pb-Pb collisions at root s(NN) = 2.76 TeV were measured. Jets were reconstructed using the anti-k(T) jet algorithm with a resolution parameter of R = 0.2 from charged and neutral particles, utilizing the ALICE tracking detectors and Electromagnetic Calorimeter (EMCal). The jet p(T) spectra are reported in the pseudorapidity interval of \eta(jet)\ 5 GeV/c to suppress jets constructed from the combinatorial background in Pb-Pb collisions. The leading charged particle requirement applied to jet spectra both in pp and Pb-Pb collisions had a negligible effect on the R-AA. The nuclear modification factor R-AA was found to be 0.28 +/- 0.04 in 0-10% and 0.35 +/- 0.04 in 10-30% collisions, independent of p(T), jet within the uncertainties of the measurement. The observed suppression is in fair agreement with expectations from two model calculations with different approaches to jet quenching. (C) 2015 CERN for the benefit of the ALICE Collaboration. Published by Elsevier B.V.Peer reviewe

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Centrality dependence of high-pT D meson suppression in Pb-Pb collisions at 1asNN = 2.76 TeV

The nuclear modification factor, RAA, of the prompt charmed mesons D0, D+ and D 17+, and their antiparticles, was measured with the ALICE detector in Pb-Pb collisions at a centre-of-mass energy 1asNN = 2.76 TeV in two transverse momentum intervals, 5 < pT < 8GeV/c and 8 < pT < 16GeV/c, and in six collision centrality classes. The RAA shows a maximum suppression of a factor of 5\u20136 in the 10% most central collisions. The suppression and its centrality dependence are compatible within uncertainties with those of charged pions. A comparison with the RAA of non-prompt J/\u3c8 from B meson decays, measured by the CMS Collaboration, hints at a larger suppression of D mesons in the most central collisions

Centrality dependence of inclusive J/\u3c8 production in p-Pb collisions at 1asNN = 5.02 TeV

We present a measurement of inclusive J/\u3c8 production in p-Pb collisions at 1asNN = 5.02TeV as a function of the centrality of the collision, as estimated from the energy deposited in the Zero Degree Calorimeters. The measurement is performed with the ALICE detector down to zero transverse momentum, pT, in the backward ( 124.46 < ycms < 122.96) and forward (2.03 < ycms < 3.53) rapidity intervals in the dimuon decay channel and in the mid-rapidity region ( 121.37 < ycms < 0.43) in the dielectron decay channel. The backward and forward rapidity intervals correspond to the Pb-going and p-going direction, respectively. The pT-differential J/\u3c8 production cross section at backward and forward rapidity is measured for several centrality classes, together with the corresponding average pT and pT2 values. The nuclear modification factor is presented as a function of centrality for the three rapidity intervals, and as a function of pT for several centrality classes at backward and forward rapidity. At mid- and forward rapidity, the J/\u3c8 yield is suppressed up to 40% compared to that in pp interactions scaled by the number of binary collisions. The degree of suppression increases towards central p-Pb collisions at forward rapidity, and with decreasing pT of the J/\u3c8. At backward rapidity, the nuclear modification factor is compatible with unity within the total uncertainties, with an increasing trend from peripheral to central p-Pb collisions

Oestrogen replacement fails to fully revert ovariectomy‑induced changes in adipose tissue monoglycerides, diglycerides and cholesteryl esters of rats fed a lard‑enriched diet

Menopause may be accompanied by abdominal obesity and inflammation, conditions accentuated by high-fat intake, especially of saturated fat (SFA)-rich diets. We investigated the consequences of high-SFA intake on the fatty acid (FA) profile of monoglycerides, diglycerides and cholesteryl esters from retroperitoneal white adipose tissue (RET) of rats with ovariectomy-induced menopause, and the effect of oestradiol replacement. Wistar rats were either ovariectomized (Ovx) or sham operated (Sham) and fed either standard chow (C) or lard-enriched diet (L) for 12 weeks. Half of the Ovx rats received 17β-oestradiol replacement (Ovx+E2). Body weight and food intake were measured weekly. RET neutral lipids were chromatographically separated and FAs analysed by gas chromatography. Ovariectomy alone increased body weight, feed effciency, RET mass, leptin and insulin levels, leptin/adiponectin ratio, HOMA-IR and HOMA-β indexes. OvxC+E2 showed attenuation in nearly all blood markers. HOMA-β index was restored in OvxL+E2. OvxC showed significantly disturbed SFA and polyunsaturated FA (PUFA) profile in RET cholesteryl esters (CE). OvxC also showed increased monounsaturated FA (MUFA) in the monoglyceride diglyceride (Mono–Di) fraction. Similar changes were not observed in OvxL, although increased SFA and decreased PUFA was observed in Mono–Di. Overall, HRT was only partially able to revert changes induced by ovariectomy. There appears to be increased mobilization of essential FA in Ovx via CE, which is a dynamic lipid species. The same results were not found in Mono–Di, which are more inert. HRT may be helpful to preserve FA profile in visceral fat, but possibly not wholly sufficient in reverting the metabolic effects induced by menopause

Palatable High Fat Diet Modifies the Adipose Tissue Metabolism in Rats with Respect to the Age and the Treatment Time

We have previously shown that the continuous intake of a palatable hyperlipidic diet (H) or alternate cycles of the standard diet (C) and H diets (CH diet) induced obesity in rats. In this study we investigate the relevance of the animal's age and duration of treatment with these diets on glucose metabolism in isolated adipocytes and adiponectin gene expression and leptin receptors density. Male Wistar rats received C, H, or CH diets, during 3 different periods: from 30 to 60; from 30 to 90 or from 60 to 90 days old. The diameter, the area and volume of the isolated adipocytes from retroperitoneal adipose tissue (RET) increased in H and CH (30-60 and 30-90); and from epididymal adipose tissue (EPI) in H and CH (30-90). The glucose incorporation rate in lipids was higher in isolated adipocytes RET of all animals treated with CH diet, as well as in EPI from H30-90 and CH60-90. Adipocytes of RET in H30-90, CH30-90, CH60-90 and CH30-60 groups and of EPI in H and CH (30-90) and CH60-90 groups, observe an increase of CO2 glucose oxidation rate into CO2. The leptin receptor density increased in RET of H and CH (30-60) groups and in EPI of CH30-90. Serum triacylglycerol level increased in all CH groups. These findings showed that the intake H and CH diets cause hypertrophy of adipocytes and depend on treatment time, animal age and the type of fat deposit. Moreover, may have atherogenic effect by inhibiting the gene expression of adiponectin

Dietary Whey Protein Lessens Several Risk Factors For Metabolic Diseases: A Review

Obesity and type 2 diabetes mellitus (DM) have grown in prevalence around the world, and recently, related diseases have been considered epidemic. Given the high cost of treatment of obesity/DM-associated diseases, strategies such as dietary manipulation have been widely studied; among them, the whey protein diet has reached popularity because it has been suggested as a strategy for the prevention and treatment of obesity and DM in both humans and animals. Among its main actions, the following activities stand out: reduction of serum glucose in healthy individuals, impaired glucose tolerance in DM and obese patients; reduction in body weight; maintenance of muscle mass; increases in the release of anorectic hormones such as cholecystokinin, leptin, and glucagon like-peptide 1 (GLP-1); and a decrease in the orexigenic hormone ghrelin. Furthermore, studies have shown that whey protein can also lead to reductions in blood pressure, inflammation, and oxidative stress. © 2012 Souza et al.; licensee BioMed Central Ltd.11Giskes, K., Van Lenthe, F., Avendano-Pabon, M., Brug, J., A systematic review of environmental factors and obesogenic dietary intakes among adults: Are we getting closer to understanding obesogenic environments? (2011) Obes Rev, 12, pp. 595-e106. , 10.1111/j.1467-789X.2010.00769.x 20604870Pimentel, G.D., Arimura, S.T., De Moura, B.M., Silva, M.E., De Sousa, M.V., Short-term nutritional counseling reduces body mass index, waist circumference, triceps skinfold and triglycerides in women with metabolic syndrome (2010) Diabetol Metab Syndr, 2, p. 13. , 10.1186/1758-5996-2-13 20181143(2012) Global Strategy on Diet, Physical Activity and Health: Obesity and Overweight, , http://www.who.int/dietphysicalactivity/publications/facts/obesity/en, WHO, World Health Organization, GenevaMisra, A., Khurana, L., Obesity-related non-communicable diseases: South Asians vs White Caucasians (2011) Int J Obes (Lond), 35, pp. 167-187. , 10.1038/ijo.2010.135Gigante, D.P., Moura, E.C., Sardinha, L.M., Prevalence of overweight and obesity and associated factors, Brazil, 2006 (2009) Rev Saude Publica, 43 (SUPPL. 2), pp. 83-89. , 19936502Rodrigues, T.C., Canani, L.H., Gross, J.L., Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes mellitus (2010) Arq Bras Cardiol, 94, pp. 134-139. , 10.1590/S0066-782X2010000100020 20414537Mortensen, L.S., Hartvigsen, M.L., Brader, L.J., Astrup, A., Schrezenmeir, J., Holst, J.J., Thomsen, C., Hermansen, K., Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: Comparison of whey, casein, gluten, and cod protein (2009) Am J Clin Nutr, 90, pp. 41-48. , 10.3945/ajcn.2008.27281 19458012De Oliveira, E.P., Manda, R.M., Torezan, G.A., Corrente, J.E., Burini, R.C., Dietary, anthropometric, and biochemical determinants of plasma high-density lipoprotein-cholesterol in free-living adults (2011) Cholesterol, 2011, p. 851750. , 21490775Takahashi, M.M., De Oliveira, E.P., Moreto, F., Portero-Mclellan, K.C., Burini, R.C., Association of dyslipidemia with intakes of fruit and vegetables and the body fat content of adults clinically selected for a lifestyle modification program (2010) Arch Latinoam Nutr, 60, pp. 148-154. , 21425719Frestedt, J.L., Zenk, J.L., Kuskowski, M.A., Ward, L.S., Bastian, E.D., A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: A randomized human clinical study (2008) Nutrition and Metabolism, 5 (1), p. 8. , DOI 10.1186/1743-7075-5-8Solah, V.A., Kerr, D.A., Adikara, C.D., Meng, X., Binns, C.W., Zhu, K., Devine, A., Prince, R.L., Differences in satiety effects of alginate- and whey protein-based foods (2010) Appetite, 54, pp. 485-491. , 10.1016/j.appet.2010.01.019 20144671Pimentel, G.D., Portero-Mclellan, K.C., De Oliveira, E.P., Spada, A.P., Oshiiwa, M., Zemdegs, J.C., Barbalho, S.M., Long-term nutrition education reduces several risk factors for type 2 diabetes mellitus in Brazilians with impaired glucose tolerance (2010) Nutr Res, 30, pp. 186-190. , 10.1016/j.nutres.2010.03.003 20417879Pilvi, T.K., Harala, S., Korpela, R., Mervaala, E.M., Effects of high-calcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL/6J mice (2009) Br J Nutr, 102, pp. 337-341. , 10.1017/S0007114508199445 19622178Bowen, J., Noakes, M., Clifton, P.M., Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad Libitum energy intake (2006) Journal of Clinical Endocrinology and Metabolism, 91 (8), pp. 2913-2919. , http://jcem.endojournals.org/cgi/reprint/91/8/2913, DOI 10.1210/jc.2006-0609Petersen, B.L., Ward, L.S., Bastian, E.D., Jenkins, A.L., Campbell, J., Vuksan, V., A whey protein supplement decreases post-prandial glycemia (2009) Nutr J, 8, p. 47. , 10.1186/1475-2891-8-47 19835582Gunnarsson, P.T., Winzell, M.S., Deacon, C.F., Larsen, M.O., Jelic, K., Carr, R.D., Ahren, B., Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice (2006) Endocrinology, 147 (7), pp. 3173-3180. , http://endo.endojournals.org/cgi/reprint/147/7/3173, DOI 10.1210/en.2005-1442Takasaki, K., Nakajima, T., Ueno, K., Nomoto, Y., Higo, K., Effects of combination treatment with dipeptidyl peptidase IV inhibitor and sulfonylurea on glucose levels in rats (2004) Journal of Pharmacological Sciences, 95 (2), pp. 291-293. , DOI 10.1254/jphs.SC0040043Monograph (2008) Altern Med Rev, 13, pp. 341-347. , 19152482 Whey proteinHaraguchi, F.K., Pedrosa, M.L., De Paula, H., Dos Santos, R.C., Silva, M.E., Influência das proteínas do soro sobre enzimas hapáticas, perfil lipídico e formação ássea de ratos hipercolesterolêmicos (2009) Rev Nutr, 22, pp. 517-525Luhovyy, B.L., Akhavan, T., Anderson, G.H., Whey proteins in the regulation of food intake and satiety (2007) J Am Coll Nutr, 26, pp. 704S-712S. , 18187437Haraguchi, F.K., De Abreu, W.C., De Paula, H., Proteínas do soro do leite: Composição, propriedades nutricionais, aplicaçes no esporte e benefícios para a saúde humana (2006) Rev Nutr, 19, pp. 479-488Hulmi, J.J., Lockwood, C.M., Stout, J.R., Effect of protein/essential amino acids and resistance training on skeletal muscle hypertrophy: A case for whey protein (2010) Nutr Metab (Lond), 7, p. 51. , 10.1186/1743-7075-7-51Pal, S., Ellis, V., Ho, S., Acute effects of whey protein isolate on cardiovascular risk factors in overweight, post-menopausal women (2010) Atherosclerosis, 212, pp. 339-344. , 10.1016/j.atherosclerosis.2010.05.032 20561625Barnett, M.P., Phillips, A.R., Harris, P.M., Cooper, G.J., Impaired insulin secretion in perfused pancreases isolated from offspring of female rats fed a low protein whey-based diet (2008) Jop, 9, pp. 477-488. , 18648139Pacheco, M.T.B., Dias, N.F.G., Baldini, V.L.S., Tanikawa, C., Sgarbieri, V.C.S., Propriedades funcionais de hidrolisados obtidos a partir de concentrados protéicos de soro de leite (2005) Ciênc Tecnol Aliment, 25, pp. 333-338. , 22764363Pal, S., Ellis, V., The acute effects of four protein meals on insulin, glucose, appetite and energy intake in lean men (2010) Br J Nutr, 104, pp. 1241-1248. , 10.1017/S0007114510001911 20456814Hackney, K.J., Bruenger, A.J., Lemmer, J.T., Timing protein intake increases energy expenditure 24h after resistance training (2010) Med Sci Sports Exerc, 42, pp. 998-1003. , 10.1249/MSS.0b013e3181c12976 19997003Lan-Pidhainy, X., Wolever, T.M., The hypoglycemic effect of fat and protein is not attenuated by insulin resistance (2010) Am J Clin Nutr, 91, pp. 98-105. , 10.3945/ajcn.2009.28125 19923374Pilvi, T.K., Korpela, R., Huttunen, M., Vapaatalo, H., Mervaala, E.M., High-calcium diet with whey protein attenuates body-weight gain in high-fat-fed C57Bl/6J mice (2007) British Journal of Nutrition, 98 (5), pp. 900-907. , DOI 10.1017/S0007114507764760, PII S0007114507764760Muro Urista, C., Alvarez Fernandez, R., Riera Rodriguez, F., Arana Cuenca, A., Tellez Jurado, A., Review: Production and functionality of active peptides from milk (2011) Food Sci Technol Int, 17, pp. 293-317. , 10.1177/1082013211398801 21917640Graf, S., Egert, S., Heer, M., Effects of whey protein supplements on metabolism: Evidence from human intervention studies (2011) Curr Opin Clin Nutr Metab Care, 14, pp. 569-580. , 10.1097/MCO.0b013e32834b89da 21912246Gilbert, J.A., Bendsen, N.T., Tremblay, A., Astrup, A., Effect of proteins from different sources on body composition (2011) Nutr Metab Cardiovasc Dis, 21 (SUPPL. 2), pp. 216-231. , 21565478Dougkas, A., Reynolds, C.K., Givens, I.D., Elwood, P.C., Minihane, A.M., Associations between dairy consumption and body weight: A review of the evidence and underlying mechanisms (2011) Nutr Res Rev, pp. 1-24Madureira, A.R., Tavares, T., Gomes, A.M., Pintado, M.E., Malcata, F.X., Invited review: Physiological properties of bioactive peptides obtained from whey proteins (2010) J Dairy Sci, 93, pp. 437-455. , 10.3168/jds.2009-2566 20105516Baer, D.J., Stote, K.S., Paul, D.R., Harris, G.K., Rumpler, W.V., Clevidence, B.A., Whey protein but not soy protein supplementation alters body weight and composition in free-living overweight and obese adults (2011) J Nutr, 141, pp. 1489-1494. , 10.3945/jn.111.139840 21677076Burton-Freeman, B.M., Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK) (2008) Physiol Behav, 93, pp. 379-387. , 10.1016/j.physbeh.2007.09.010 17964616Pichon, L., Potier, M., Tome, D., Mikogami, T., Laplaize, B., Martin-Rouas, C., Fromentin, G., High-protein diets containing different milk protein fractions differently influence energy intake and adiposity in the rat (2008) British Journal of Nutrition, 99 (4), pp. 739-748. , DOI 10.1017/S0007114507831709, PII S0007114507831709Pilvi, T.K., Storvik, M., Louhelainen, M., Merasto, S., Korpela, R., Mervaala, E.M., Effect of dietary calcium and dairy proteins on the adipose tissue gene expression profile in diet-induced obesity (2008) J Nutrigenet Nutrigenomics, 1, pp. 240-251. , 10.1159/000151238 19776631Pal, S., Ellis, V., Dhaliwal, S., Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals (2010) Br J Nutr, 104, pp. 716-723. , 10.1017/S0007114510000991 20377924Kasim-Karakas, S.E., Cunningham, W.M., Tsodikov, A., Relation of nutrients and hormones in polycystic ovary syndrome (2007) American Journal of Clinical Nutrition, 85 (3), pp. 688-694. , http://www.ajcn.org/cgi/reprint/85/3/688Pal, S., Ellis, V., The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals (2010) Obesity (Silver Spring), 18, pp. 1354-1359. , 10.1038/oby.2009.397Pimentel, G.D., Mota, J.F., Oyama, L.M., Oxyntomodulin and obesity (2009) Rev Nutr, 22, pp. 727-737. , 10.1590/S1415-52732009000500013Pimentel, G.D., Dornellas, A.P., Rosa, J.C., Lira, F.S., Cunha, C.A., Boldarine, V.T., De Souza, G.I., Oyama, L.M., High-fat diets rich in soy or fish oil distinctly alter hypothalamic insulin signaling in rats (2012) J Nutr Biochem, 23, pp. 822-828. , 10.1016/j.jnutbio.2011.04.006 21852082Carvalheira, J.B.C., Ribeiro, E.B., Araujo, E.P., Guimaraes, R.B., Telles, M.M., Torsoni, M., Gontijo, J.A.R., Saad, M.J.A., Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats (2003) Diabetologia, 46 (12), pp. 1629-1640. , DOI 10.1007/s00125-003-1246-xRopelle, E.R., Flores, M.B., Cintra, D.E., Rocha, G.Z., Pauli, J.R., Morari, J., De Souza, C.T., Guadagnini, D., IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition (2010) PLoS Biol, 8Frid, A.H., Nilsson, M., Holst, J.J., Bjorck, I.M.E., Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects (2005) American Journal of Clinical Nutrition, 82 (1), pp. 69-75Li, C., Chen, P., Palladino, A., Narayan, S., Russell, L.K., Sayed, S., Xiong, G., Butt, Y.M., Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase (2010) J Biol Chem, 285, pp. 31806-31818. , 10.1074/jbc.M110.123638 20670938Mortensen, L.S., Holmer-Jensen, J., Hartvigsen, M.L., Jensen, V.K., Astrup, A., De Vrese, M., Holst, J.J., Hermansen, K., Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes (2012) Eur J Clin Nutr, , In pressSantoro, S., Velhote, M.C.P., Manzoni, C.E., Mechenas, A.S.G., Strassmann, V., Scheinberg, V., Adaptação digestiva: Uma nova proposta cirúrgica para tratar a obesidade com base em fisiologia e evolução (2003) Einstein, 1, pp. 95-98Mannucci, E., Pala, L., Ciani, S., Bardini, G., Pezzatini, A., Sposato, I., Cremasco, F., Rotella, C.M., Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus (2005) Diabetologia, 48 (6), pp. 1168-1172. , DOI 10.1007/s00125-005-1749-8Veldhorst, M.A., Nieuwenhuizen, A.G., Hochstenbach-Waelen, A., Van Vught, A.J., Westerterp, K.R., Engelen, M.P., Brummer, R.J., Westerterp-Plantenga, M.S., Dose-dependent satiating effect of whey relative to casein or soy (2009) Physiol Behav, 96, pp. 675-682. , 10.1016/j.physbeh.2009.01.004 19385022Pinto, L.C., Ricardo, E.D., Leitao, C.B., Kramer, C.K., Zanatta, C.M., Gross, J.L., Canani, L.H., Inadequate blood pressure control in patients with type 2 diabetes mellitus (2010) Arq Bras Cardiol, 94, pp. 651-655. , 10.1590/S0066-782X2010005000034 20428720Takahashi, M.M., De Oliveira, E.P., De Carvalho, A.L., De Souza Dantas, L.A., Burini, F.H., Portero-Mclellan, K.C., Burini, R.C., Metabolic syndrome and dietary components are associated with coronary artery disease risk score in free-living adults: A cross-sectional study (2011) Diabetol Metab Syndr, 3, p. 7. , 10.1186/1758-5996-3-7 21554698Lee, Y.-M., Skurk, T., Hennig, M., Hauner, H., Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension (2007) European Journal of Nutrition, 46 (1), pp. 21-27. , DOI 10.1007/s00394-006-0625-8Tome, D., Schwarz, J., Darcel, N., Fromentin, G., Protein, amino acids, vagus nerve signaling, and the brain (2009) Am J Clin Nutr, 90, pp. 838S-843S. , 10.3945/ajcn.2009.27462W 19640948Valentino, M.A., Lin, J.E., Snook, A.E., Li, P., Kim, G.W., Marszalowicz, G., Magee, M.S., Waldman, S.A., A uroguanylin-GUCY2C endocrine axis regulates feeding in mice (2011) J Clin Invest, 121, pp. 3578-3588. , 10.1172/JCI57925 21865642Pimentel, G.D., Zemdegs, J.C., Foods and nutrients modulates the release of anorexigenic gastrointestinal hormones (2010) Acta Med Port, 23, pp. 891-900. , 21144331Pimentel, G.D., Micheletti, T.O., Pace, F., Rosa, J.C., Santos, R.V., Lira, F.S., Gut-central nervous system axis is a target for nutritional therapies (2012) Nutr J, 11, p. 22. , 10.1186/1475-2891-11-22 22490672Foltz, M., Ansems, P., Schwarz, J., Tasker, M.C., Lourbakos, A., Gerhardt, C.C., Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor (2008) Journal of Agricultural and Food Chemistry, 56 (3), pp. 837-843. , DOI 10.1021/jf072611hCota, D., Proulx, K., Blake Smith, K.A., Kozma, S.C., Thomas, G., Woods, S.C., Seeley, R.J., Hypothalamic mTOR signaling regulates food intake (2006) Science, 312 (5775), pp. 927-930. , DOI 10.1126/science.1124147Ropelle, E.R., Pauli, J.R., Fernandes, M.F., Rocco, S.A., Marin, R.M., Morari, J., Souza, K.K., Gontijo, J.A., A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss (2008) Diabetes, 57, pp. 594-605. , 10.2337/db07-0573 18057094Kume, H., Okazaki, K., Sasaki, H., Hepatoprotective effects of whey protein on D-galactosamine-induced hepatitis and liver fibrosis in rats (2006) Bioscience, Biotechnology and Biochemistry, 70 (5), pp. 1281-1285. , http://www.jstage.jst.go.jp/article/bbb/70/5/1281/_pdf, DOI 10.1271/bbb.70.1281Heilbronn, L.K., De Jonge, L., Frisard, M.I., Delany, J.P., Larson-Meyer, D.E., Rood, J., Nguyen, T., Most, M.M., Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial (2006) JAMA, 295, pp. 1539-1548. , 10.1001/jama.295.13.1539 16595757Cruz-Guilloty, F., Perez, V.L., Molecular medicine: Defence against oxidative damage (2011) Nature, 478, pp. 42-43. , 10.1038/478042a 21979040Van Gaal, L.F., Mertens, I.L., De Block, C.E., Mechanisms linking obesity with cardiovascular disease (2006) Nature, 444 (7121), pp. 875-880. , DOI 10.1038/nature05487, PII NATURE05487Mercer, J.R., Yu, E., Figg, N., Cheng, K.K., Prime, T.A., Griffin, J.L., Masoodi, M., Bennett, M.R., The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+//ApoE/ mice (2012) Free Radic Biol Med, 52, pp. 841-849. , 10.1016/j.freeradbiomed.2011.11.026 22210379Ebaid, H., Salem, A., Sayed, A., Metwalli, A., Whey protein enhances normal inflammatory responses during cutaneous wound healing in diabetic rats (2011) Lipids Health Dis, 10, p. 235. , 10.1186/1476-511X-10-235 22168406Hamad, E.M., Taha, S.H., Abou Dawood, A.G., Sitohy, M.Z., Abdel-Hamid, M., Protective effect of whey proteins against nonalcoholic fatty liver in rats (2011) Lipids Health Dis, 10, p. 57. , 10.1186/1476-511X-10-57 21489294Zavorsky, G.S., Kubow, S., Grey, V., Riverin, V., Lands, L.C., An open-label dose - Response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements (2007) International Journal of Food Sciences and Nutrition, 58 (6), pp. 429-436. , DOI 10.1080/09637480701253581, PII 779415967Chitapanarux, T., Tienboon, P., Pojchamarnwiputh, S., Leelarungrayub, D., Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients (2009) J Gastroenterol Hepatol, 24, pp. 1045-1050. , 10.1111/j.1440-1746.2009.05865.x 19638084De Aguilar-Nascimento, J.E., Prado Silveira, B.R., Dock-Nascimento, D.B., Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: A double-blind randomized trial (2011) Nutrition, 27, pp. 440-444. , 10.1016/j.nut.2010.02.013 21167685Xu, R., Liu, N., Xu, X., Kong, B., Antioxidative effects of whey protein on peroxide-induced cytotoxicity (2011) J Dairy Sci, 94, pp. 3739-3746. , 10.3168/jds.2010-3891 21787910Takayanagi, T., Sasaki, H., Kawashima, A., Mizuochi, Y., Hirate, H., Sugiura, T., Azami, T., Sobue, K., A new enteral diet, MHN-02, which contains abundant antioxidants and whey peptide, protects against carbon tetrachloride-induced hepatitis (2011) JPEN J Parenter Enteral Nutr, 35, pp. 516-522. , 10.1177/0148607110381599 21700967Abdel-Aziem, S.H., Hassan, A.M., Abdel-Wahhab, M.A., Dietary supplementation with whey protein and ginseng extract counteracts oxidative stress and DNA damage in rats fed an aflatoxin-contaminated diet (2011) Mutat Res, 723, pp. 65-71. , 21536149Gad, A.S., Khadrawy, Y.A., El-Nekeety, A.A., Mohamed, S.R., Hassan, N.S., Abdel-Wahhab, M.A., Antioxidant activity and hepatoprotective effects of whey protein and Spirulina in rats (2011) Nutrition, 27, pp. 582-589. , 10.1016/j.nut.2010.04.002 20708378Yalcin, A.S., Emerging therapeutic potential of whey proteins and peptides (2006) Curr Pharm des, 12, pp. 1637-1643. , 10.2174/138161206776843296 1672987